Benzodiazepines, but not antidepressants or neuroleptics, induce dose‐dependent development of tolerance to lorazepam in psychiatric patients

Authors:

Abstract
ABSTRACT– Psychomotor effects of oral lorazepam 3 mg were studied in psychiatric patients stratified into four groups: 1) a group of six patients with no previous use of psychotrophic drugs (NoD), 2) a group of 12 patients treated with antidepressants and/or neuroleptics (PsyD), 3) a group of 10 patients treated with low doses of benzodiazepines (BZs) (lowBZ), and 4) a group of nine patients treated with high doses of BZs (highBZ). Similar objective psychomotor tests and subjective assessments were administered under single‐blind conditions to all treatment groups at baseline, after intake of placebo, and after intake of 3 mg lorazepam. Both lorazepam (CGC) and total BZs (bioassay) in serum were assayed. The results demonstrate that treatment with BZs induce dose‐dependent development of tolerance to psychomotor effects of lorazepam. Antidepressants and neuroleptics failed to induce cross‐tolerance to lorazepam. The rise in serum lorazepam concentrations after lorazepam intake was similar (about 28 μg/1) in all treatment groups, suggesting a functional, not dispositional, tolerance. However, the initial learning effect in psychomotor performance was poorer among BZ users than among others.

This publication has 28 references indexed in Scilit: